Introduction
Stevens-Johnson syndrome is caused by an abnormal immune reaction, most often triggered by a medication and less commonly by an infection or other medical stressor. The disorder develops when the immune system mistakenly identifies a drug-related compound or infection-associated signal as dangerous and launches an aggressive cytotoxic response against the skin and mucous membranes. This response leads to widespread death of the cells that form the outer layers of the body. The main causes discussed in this article include medications, infections, genetic susceptibility, and certain underlying health conditions that increase vulnerability to this immune misfire.
Biological Mechanisms Behind the Condition
To understand what causes Stevens-Johnson syndrome, it helps to first understand the normal role of the immune system. Under ordinary circumstances, immune cells are trained to distinguish between harmless substances and genuine threats such as viruses or bacteria. T cells, a major arm of adaptive immunity, help identify infected or abnormal cells and coordinate a controlled defense. In Stevens-Johnson syndrome, this system becomes misdirected. Instead of limiting its response to an actual pathogen or foreign molecule, it targets the body’s own skin cells, especially the keratinocytes that make up the epidermis.
The key biological event is an immune-mediated attack that causes extensive keratinocyte apoptosis, meaning programmed cell death. Several immune signals are involved, including cytotoxic T lymphocytes and natural killer cells. These cells release molecules such as perforin, granzyme, and granulysin, which can damage or kill target cells. Granulysin appears to be particularly important in Stevens-Johnson syndrome because it can directly injure skin cells and is found at high levels in affected tissue. The result is separation of the epidermis from the underlying skin layers and erosion of mucous membranes.
This reaction is not simply a generic allergy. It is a severe, delayed hypersensitivity response that usually develops after the immune system has had time to recognize and amplify its response to a trigger. In drug-induced cases, the medication may bind to proteins in the body or alter how immune receptors perceive those proteins. In genetically susceptible individuals, this can create an immune signal strong enough to produce massive tissue injury rather than a mild rash.
Primary Causes of Stevens-Johnson Syndrome
The most common cause of Stevens-Johnson syndrome is medication exposure. Certain drugs are repeatedly associated with the condition, especially in the days to weeks after starting treatment. Antibiotics, particularly sulfonamides, are among the classic triggers. Anticonvulsants such as carbamazepine, lamotrigine, phenytoin, and phenobarbital are also strongly linked. Allopurinol, used to treat gout, is another major cause. Some nonsteroidal anti-inflammatory drugs, particularly oxicam-type NSAIDs, and certain antiretroviral agents have also been implicated.
These drugs are thought to trigger Stevens-Johnson syndrome by acting as antigens themselves or by becoming chemically modified in a way that makes them visible to the immune system. In some cases, a drug or its metabolite binds to human leukocyte antigen, or HLA, molecules on antigen-presenting cells. This alters the immune presentation of peptides and can activate T cells in a way that would not normally occur. Once activated, these T cells release inflammatory and cytotoxic signals that damage the skin and mucosa. The immune injury may continue even after the drug is stopped because the inflammatory cascade has already been set in motion.
Infections are the second major category of causes. Mycoplasma pneumoniae is a well-known infectious trigger, especially in children and adolescents. Viral infections, including herpes viruses and influenza-like illnesses, have also been reported in association with the syndrome. In infection-associated cases, the immune system is already activated against the infectious organism, and in some individuals the immune response becomes exaggerated or misdirected toward skin tissues. Infection may also prime the body so that a medication taken at the same time becomes more likely to provoke the syndrome.
Less commonly, Stevens-Johnson syndrome can appear after exposure to vaccines, radiation, or physical stressors, although these are far less common than drug and infection triggers. In such cases, the exact mechanism may still involve immune activation, but the trigger is less straightforward than it is with a known high-risk medication.
Contributing Risk Factors
Genetic factors are among the most important contributors to susceptibility. Certain HLA types are strongly associated with increased risk of Stevens-Johnson syndrome after exposure to specific drugs. For example, HLA-B*15:02 is linked to carbamazepine-induced Stevens-Johnson syndrome in many Asian populations, while HLA-B*58:01 is associated with allopurinol-related reactions. These HLA variants influence how the immune system presents drug-related molecules to T cells. If the presentation is unusually efficient or unusually activating, the immune response may become severe enough to produce widespread epidermal injury.
Inherited differences in drug metabolism can also matter. Some individuals break down medications more slowly or generate reactive metabolites that persist longer in the body. When drug clearance is reduced, the immune system is exposed to the trigger for a longer period, which may increase the chance of a severe reaction. Variations in detoxification enzymes, including those involved in hepatic metabolism, can therefore contribute indirectly to risk.
Age and general health status may influence susceptibility as well. Although Stevens-Johnson syndrome can occur at any age, it is often more serious in older adults, partly because they are more likely to take multiple medications and have reduced physiologic reserve. Chronic illnesses such as HIV infection, cancer, and autoimmune disease can also increase risk. These conditions alter immune regulation, may require medications known to provoke the syndrome, and can impair the body’s ability to control inflammatory responses.
Environmental exposures may play an indirect role. Exposure to new medications during periods of acute illness, polypharmacy, or recent hospitalization increases the likelihood of encountering a trigger. In some cases, concurrent infection or inflammatory stress may lower the threshold for an immune reaction. Lifestyle factors are less direct causes, but poor nutritional status, alcohol-related liver dysfunction, or delayed access to care can affect drug handling and immune stability, making a severe reaction more likely once exposure occurs.
How Multiple Factors May Interact
Stevens-Johnson syndrome rarely arises from a single isolated event. More often, it reflects the interaction of a trigger with a vulnerable immune background. A person may carry a susceptibility HLA type, have reduced drug metabolism, and then begin a high-risk medication during an active infection. Each factor adds to the probability that the immune system will respond inappropriately. The drug supplies the trigger, the genetic background shapes immune recognition, and infection or inflammation intensifies the response.
These interactions matter because the immune system is not operating in a vacuum. Cytokines released during infection can increase antigen presentation and T-cell activation. Reduced clearance of a drug can prolong exposure to the immune trigger. Tissue inflammation can also lower the threshold for cell death once cytotoxic pathways are activated. In effect, multiple biological systems reinforce one another, making the final response larger and more destructive than any single factor would predict alone.
Variations in Causes Between Individuals
The cause of Stevens-Johnson syndrome can differ substantially from one person to another because susceptibility is shaped by genetics, age, organ function, immune history, and exposure patterns. One individual may develop the condition after a well-known high-risk drug, while another may react to an infection or a different medication altogether. The same drug can be tolerated by millions of people and still trigger severe disease in someone with a particular HLA profile or metabolic variant.
Age influences both exposure and response. Children are more likely to develop infection-associated cases, while older adults are more likely to experience drug-related forms because of greater medication use and slower clearance. People with kidney or liver disease may accumulate drugs or metabolites to a higher degree, which can increase immune exposure. Prior immune activation, such as a recent viral illness, may also alter the way the body interprets a later medication exposure. As a result, the same external trigger may have very different consequences depending on the biological context.
Conditions or Disorders That Can Lead to Stevens-Johnson Syndrome
Certain medical conditions are associated with a higher likelihood of Stevens-Johnson syndrome, either because they directly stimulate immune dysregulation or because they increase exposure to known triggers. HIV infection is one of the strongest risk conditions. People with HIV have altered immune control, chronic immune activation, and frequent exposure to medications that can provoke severe cutaneous reactions. These factors combine to produce a much higher incidence than in the general population.
Cancer, particularly hematologic malignancy, can also contribute. Malignancy affects immune surveillance and often requires treatment with multiple drugs, some of which may interact or alter metabolism. The immune system may be less able to maintain balance between surveillance and tolerance, making severe drug reactions more likely. Autoimmune diseases can also be relevant because they reflect an immune system already prone to dysregulation. While the autoimmune disorder itself does not cause Stevens-Johnson syndrome, the altered immune environment and the medications used to treat it may raise risk.
Respiratory and systemic infections can trigger the syndrome by creating an inflammatory state that amplifies immune signaling. Mycoplasma pneumoniae infection is particularly important because it can cause a mucocutaneous reaction that resembles or overlaps with Stevens-Johnson syndrome. In such cases, the infection likely acts as a direct immune stimulus rather than merely a background factor. Other severe infections may contribute through similar mechanisms, especially when they produce high levels of inflammatory cytokines and immune activation.
Conclusion
Stevens-Johnson syndrome develops when the immune system mounts a severe, misdirected attack on skin and mucous membrane cells. The most common triggers are medications, especially certain antibiotics, anticonvulsants, and allopurinol, followed by infections such as Mycoplasma pneumoniae. Genetic factors, particularly HLA variants, shape how the immune system recognizes these triggers and help explain why only certain individuals are affected. Additional contributors include altered drug metabolism, chronic illnesses, immune dysregulation, and overlapping environmental exposures.
Understanding the causes of Stevens-Johnson syndrome means understanding the biological pathway that turns a drug exposure or infection into a life-threatening immune reaction. The condition is not random; it reflects a specific failure of immune tolerance, antigen presentation, and cytotoxic regulation. That is why the same trigger can be harmless in one person and catastrophic in another. The combination of exposure, susceptibility, and immune activation determines whether the disease develops.